On February 27, 2025, the Government of Canada and Manitoba signed the first national pharmacare agreements under Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”), which received royal assent on October...more
3/11/2025
/ Canada ,
Drug Pricing ,
Government Agencies ,
Health Insurance ,
Health Technology ,
Healthcare ,
Healthcare Reform ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health
Health Canada recently announced that it is exploring a regulatory pathway that would allow products containing cannabidiol (“CBD”) to be purchased without a prescription. Under the current regulatory scheme, all health...more
3/10/2025
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Clinical Trials ,
Distributors ,
Health Canada ,
Hemp ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Regulatory Agenda ,
Regulatory Requirements ,
THC
Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”) received royal assent on October 10, 2024 and established a framework for national pharmacare. On February 27, 2025, the Hon. Mark Holland, Canada’s...more
On December 28, 2024, Health Canada published a regulatory proposal in the Canada Gazette, Part I, Volume 158, Number 52, introducing amendments to the Food and Drug Regulations, CRC, c 870 and the Medical Devices...more
1/20/2025
/ Canada ,
Health Canada ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Proposed Amendments ,
Proposed Rules ,
Public Health ,
Regulatory Agenda ,
Reporting Requirements ,
Supply Chain
Friday, the Federal Government issued correspondence to the provinces and territories regarding its newly introduced Canada Health Act Services Policy. As set out in this correspondence from the Minister of Health, the CHA...more
The Canadian government, through Environment and Climate Change Canada (“ECCC”), issued a notice (the “Notice”) under the Canadian Environmental Protection Act, 1999 (“CEPA”), outlining critical reporting requirements for...more
On October 10, 2024, Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”) received Royal Assent. This legislation establishes a framework for a national universal pharmacare system, aiming to enhance the...more
The Regulations Amending Certain Regulations Concerning the Disclosure of Cosmetic Ingredients (SOR/2024-63) (the “Amended Cosmetic Regulations), published on April 24, 2024, took effect on October 9th (with the exception of...more
10/17/2024
/ Canada ,
Consumer Product Companies ,
Cosmetics ,
Manufacturers ,
New Regulations ,
Personal Care Products ,
Popular ,
Product Labels ,
Public Health ,
Regulatory Reform ,
Retail Market
On December 17, 2024, recent amendments to the Food and Drug Regulations (FDR) and the Medical Devices Regulations (MDR) relating to the recall of drugs and medical devices will come into force....more
Ontario has (finally!) made the call to community surgical and diagnostic centers for applications for new licences under the Integrated Community Health Services Centres Act, 2023 (the Act) to provide MRI and CT...more